Green Thumb Industries (GTBIF) Other Non-Current Assets (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Other Non-Current Assets came in at $4.4 million in Q1 2026, up 1.63% YoY from $4.4 million in Q1 2025, and up 111.25% on a QoQ basis from $2.1 million in Q4 2025.
Green Thumb Industries (GTBIF) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Other Non-Current Assets data on file, last reported at $4.4 million in Q1 2026.
- Quarterly Other Non-Current Assets rose 1.63% year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (up 1.63% YoY) and the FY2025 annual result came in at $2.1 million, down 3.23% from the prior year.
- Other Non-Current Assets grew to $4.4 million in Q1 2026, from $2.1 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $4.4 million in Q1 2026 to a low of $2.0 million in Q2 2025.
- A 5-year average of $2.8 million and a median of $2.6 million in 2024 frame the typical range for Other Non-Current Assets.
- The widest YoY moves for Other Non-Current Assets: up 69.54% in 2025, down 21.57% in 2025.
- Tracing GTBIF's Other Non-Current Assets over 5 years: stood at $3.1 million in 2022, then decreased by 16.44% to $2.6 million in 2023, then slipped by 15.25% to $2.2 million in 2024, then slipped by 3.23% to $2.1 million in 2025, then jumped by 111.25% to $4.4 million in 2026.
- The last three Other Non-Current Assets figures came in at $4.4 million (Q1 2026), $2.1 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 13.00 Mn |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 3.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.39 Mn |
| Mar 31, 2026 | 4.43 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Sep 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 4.36 Mn |
| Dec 31, 2024 | 2.17 Mn |
| Sep 30, 2024 | 2.51 Mn |
| Jun 30, 2024 | 2.57 Mn |
| Mar 31, 2024 | 2.57 Mn |
| Dec 31, 2023 | 2.56 Mn |
| Sep 30, 2023 | 2.53 Mn |
| Jun 30, 2023 | 2.38 Mn |
| Mar 31, 2023 | 3.22 Mn |
| Dec 31, 2022 | 3.06 Mn |
| Sep 30, 2022 | 2.66 Mn |
| Jun 30, 2022 | 2.79 Mn |
| Mar 31, 2022 | 3.04 Mn |
| Dec 31, 2021 | 2.64 Mn |
| Sep 30, 2021 | 2.87 Mn |